— Know what they know.
Not Investment Advice

DRIO NASDAQ

DarioHealth Corp.
1W: -2.6% 1M: -11.5% 3M: -9.9% YTD: -38.6% 1Y: -62.4% 3Y: -90.1% 5Y: -97.7%
$6.46
+0.30 (+4.87%)
 
Weekly Expected Move ±7.5%
$5 $6 $6 $7 $7
NASDAQ · Healthcare · Medical - Specialties · Tech Score Sell · Power 36 · $47.2M mcap · 5M float · 0.389% daily turnover · Short 36% of daily vol

Supply Chain Overview

18 relationships
18
As Filer
counterparties named
0
As Counterparty
mentioned by others
5
Rel. Types
2021-04-01
Earliest Filing
2026-03-30
Latest Filing
partner: 6 investor: 5 target: 5 supplier: 1 customer: 1

Counterparties (Filed by DRIO)

18 relationships

Companies named in DRIO's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
A.G.P./Alliance Global Partners — partner Sales agent for at-the-market offering of common stock 2026-03-30 View
PsyInnovations Inc. — investor Counterparty to the terminated Loan and Security Agreement 2025-05-06 View
Avenue Venture Opportunities Fund II, L.P. — investor Counterparty to the terminated Loan and Security Agreement 2025-05-06 View
Avenue Venture — investor Counterparty to the terminated Loan and Security Agreement 2025-05-06 View
PsyInnovations, Inc. — partner Subsidiary of DarioHealth Corp. involved in the Avenue Loan Amendment. 2024-12-18 View
LabStyle Innovation Ltd. — partner Subsidiary of DarioHealth Corp. involved in the Avenue Loan Amendment. 2024-12-18 View
Twill Inc. — target Company acquired by DarioHealth Corp. mentioned in Item 8.01. 2024-12-18 View
Twill, Inc. — target Target company in the merger agreement with DarioHealth Corp. 2024-02-21 View
Avenue Venture Opportunities Fund II, L.P. — investor Holder of warrants subject to amendment agreement 2023-06-20 View
Avenue Venture Opportunities Fund, L.P. — investor Holder of warrants subject to amendment agreement 2023-06-20 View
PsyInnovations Inc. — partner Borrower subsidiary in Loan and Security Agreement 2023-05-05 View
Sanofi US Services, Inc. SNYNF partner Exclusive preferred partner, co-promotion, development collaboration and license agreement for product development and d 2022-03-04 View
Sanofi SNYNF partner Chosen as preferred partner for digital health solutions. 2022-03-02 View
Physimax Technologies Ltd. — supplier Sold technology assets to Labstyle Innovation Ltd. for stock and cash 2022-01-19 View
Labstyle Innovation Ltd. — customer Wholly owned subsidiary of DarioHealth Corp. that purchased technology assets 2022-01-19 View
PsyInnovations, Inc. — target Target company acquired by DarioHealth Corp. via merger. 2021-06-08 View
PsyInnovations, Inc. — target Target company in a merger agreement to be acquired by DarioHealth Corp. 2021-05-18 View
Upright Technologies Ltd. — target Acquired by DarioHealth Corp. through its subsidiary LabStyle Innovation Ltd. 2021-04-01 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-09-04 Officer/Director Change View
2026-08-21 Officer/Director Change; Exhibits View
2026-07-22 Material Agreement; Other Events; Exhibits Agreement View
2026-07-10 Officer/Director Change View
2026-04-13 Officer/Director Change; Other Events; Exhibits View
2026-03-30 Material Agreement; Exhibits Agreement View
2026-02-02 Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits View
2026-01-29 Submission of Matters to a Vote of Security Holders View
2025-11-10 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale Agreement View
2025-09-25 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Amendments to Art Agreement View
2025-09-19 Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla View
2025-09-12 Other Events View
2025-08-25 Amendments to Articles of Incorporation or Bylaws; Other Events; Financial Statements and Exhibits View
2025-07-23 Submission of Matters to a Vote of Security Holders View
2025-07-10 Departure/Election of Directors; Appointment of Officers View
2025-05-29 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Material Modifica Agreement View
2025-05-21 Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits View
2025-05-06 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale Agreement View
2025-04-28 Submission of Matters to a Vote of Security Holders View
2025-04-21 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms